Structure-based model profiles affinity constant of drugs with hPEPT1 for rapid virtual screening of hPEPT1’s substrate

References

• M. Drozdzik, C. Groer, J. Penski, J. Lapczuk, M. Ostrowski, Y. Lai, B. Prasad, J.D. Unadkat, W. Siegmund, and S. Oswald, Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine, Mol. Pharm. 11 (2014), pp. 3547–3555.
   PubMed Web of Science ®Google Scholar
• M. Brandsch, Drug transport via the intestinal peptide transporter PepT1, Curr. Opin. Pharmacol. 13 (2013), pp. 881–887.
   PubMed Web of Science ®Google Scholar
• R. Boggavarapu, J.M. Jeckelmann, D. Harder, Z. Ucurum, and D. Fotiadis, Role of electrostatic interactions for ligand recognition and specificity of peptide transporters, BMC Biol. 13 (2015), p. 58.
   PubMed Web of Science ®Google Scholar
• Y. Sun, J. Sun, S. Shi, Y. Jing, S. Yin, Y. Chen, G. Li, Y. Xu, and Z. He, Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine, Mol. Pharm. 6 (2009), pp. 315–325.
   PubMed Web of Science ®Google Scholar
• F. Guettou, E.M. Quistgaard, L. Tresaugues, P. Moberg, C. Jegerschold, L. Zhu, A.J. Jong, P. Nordlund, and C. Low, Structural insights into substrate recognition in proton-dependent oligopeptide transporters, EMBO Rep. 14 (2013), pp. 804–810.
   PubMed Web of Science ®Google Scholar
• S. Newstead, D. Drew, A.D. Cameron, V.L. Postis, X. Xia, P.W. Fowler, J.C. Ingram, E.P. Carpenter, M.S. Sansom, M.J. McPherson, S.A. Baldwin, and S. Iwata, Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2, EMBO J. 30 (2011), pp. 417–426.
   PubMed Web of Science ®Google Scholar
• N. Solcan, J. Kwok, P.W. Fowler, A.D. Cameron, D. Drew, S. Iwata, and S. Newstead, Alternating access mechanism in the POT family of oligopeptide transporters, EMBO J. 31 (2012), pp. 3411–3421.
   PubMed Web of Science ®Google Scholar
• K.S. Khomane, P.P. Nandekar, B. Wahlang, P. Bagul, N. Shaikh, Y.B. Pawar, C.L. Meena, A.T. Sangamwar, R. Jain, K. Tikoo, and A.K. Bansal, Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647, Mol. Pharm. 9 (2012), pp. 2458–2468.
   PubMed Web of Science ®Google Scholar
• S. Ekins, J.S. Johnston, P. Bahadduri, V.M. D'Souza, A. Ray, C. Chang, and P.W. Swaan, In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors, Pharm. Res. 22 (2005), pp. 512–517.
   PubMed Web of Science ®Google Scholar
• S. Wanchana, F. Yamashita, H. Hara, S. Fujiwara, M. Akamatsu, and M. Hashida, Two- and three-dimensional QSAR of carrier-mediated transport of beta-lactam antibiotics in Caco-2 cells, J. Pharm. Sci. 93 (2004), pp. 3057–3065.
   PubMed Web of Science ®Google Scholar
• S. Gebauer, I. Knutter, B. Hartrodt, M. Brandsch, K. Neubert, and I. Thondorf, Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1, J. Med. Chem. 46 (2003), pp. 5725–5734.
   PubMed Web of Science ®Google Scholar
• S.B. Larsen, F.S. Jorgensen, and L. Olsen, QSAR models for the human H(+)/peptide symporter, hPEPT1: Affinity prediction using alignment-independent descriptors, J. Chem. Inf. Model. 48 (2008), pp. 233–241.
   PubMed Web of Science ®Google Scholar
• S.B. Larsen, D.H. Omkvist, B. Brodin, C.U. Nielsen, B. Steffansen, L. Olsen, and F.S. Jorgensen, Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy, ChemMedChem 4 (2009), pp. 1439–1445.
   PubMed Web of Science ®Google Scholar
• R. Andersen, F.S. Jorgensen, L. Olsen, J. Vabeno, K. Thorn, C.U. Nielsen, and B. Steffansen, Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1, Pharm. Res. 23 (2006), pp. 483–492.
   PubMed Web of Science ®Google Scholar
• A. Biegel, S. Gebauer, B. Hartrodt, M. Brandsch, K. Neubert, and I. Thondorf, Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1, J. Med. Chem. 48 (2005), pp. 4410–4419.
   PubMed Web of Science ®Google Scholar
• D.H. Omkvist, S.B. Larsen, C.U. Nielsen, B. Steffansen, L. Olsen, F.S. Jorgensen, and B. Brodin, A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1), AAPS J. 12 (2010), pp. 385–396.
   PubMed Web of Science ®Google Scholar
• A. Sedykh, D. Fourches, J. Duan, O. Hucke, M. Garneau, H. Zhu, P. Bonneau, and A. Tropsha, Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions, Pharm. Res. 30 (2013), pp. 996–1007.
   PubMed Web of Science ®Google Scholar
• P. Luckner and M. Brandsch, Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: Analysis of affinity constants and comparison with PEPT1, Eur. J. Pharm. Biopharm. 59 (2005), pp. 17–24.
   PubMed Web of Science ®Google Scholar
• A. Biegel, S. Gebauer, B. Hartrodt, I. Knutter, K. Neubert, M. Brandsch, and I. Thondorf, Recognition of 2-aminothiazole-4-acetic acid derivatives by the peptide transporters PEPT1 and PEPT2, Eur. J. Pharm. Sci. 32 (2007), pp. 69–76.
   PubMed Web of Science ®Google Scholar
• L. Sun, X. Liu, R. Xiang, C. Wu, Y. Wang, Y. Sun, J. Sun, and Z. He, Structure-based prediction of human intestinal membrane permeability for rapid in silico BCS classification, Biopharm. Drug Dispos. 34 (2013), pp. 321–335.
   PubMed Web of Science ®Google Scholar
• M. Brandsch, I. Knutter, and F.H. Leibach, The intestinal H+/peptide symporter PEPT1: Structure-affinity relationships, Eur. J. Pharm. Sci. 21 (2004), pp. 53–60.
   PubMed Web of Science ®Google Scholar
• J. Kamphorst, L. Cucurull-Sanchez, and B. Jones, A performance evaluation of multiple classification models of human PEPT1 inhibitors and non-inhibitors, QSAR Comb. Sci. 26 (2007), pp. 220–226.
   Google Scholar
• Z. Yan, J. Sun, Y. Chang, Y. Liu, Q. Fu, Y. Xu, Y. Sun, X. Pu, Y. Zhang, Y. Jing, S. Yin, M. Zhu, Y. Wang, and Z. He, Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: Synthesis, transepithelial transport, chemical stability and pharmacokinetics, Mol. Pharm. 8 (2011), pp. 319–329.
   PubMed Web of Science ®Google Scholar
• S.V. Gupta, D. Gupta, J. Sun, A. Dahan, Y. Tsume, J. Hilfinger, K.D. Lee, and G.L. Amidon, Enhancing the intestinal membrane permeability of zanamivir: A carrier mediated prodrug approach, Mol. Pharm. 8 (2011), pp. 2358–2367.
   PubMed Web of Science ®Google Scholar
• H. Steingrimsdottir, A. Gruber, C. Palm, G. Grimfors, M. Kalin, and S. Eksborg, Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy, Antimicrob. Agents Chemother. 44 (2000), pp. 207–209.
   PubMed Web of Science ®Google Scholar
• M. Sugawara, W. Huang, Y.J. Fei, F.H. Leibach, V. Ganapathy, and M.E. Ganapathy, Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2, J. Pharm. Sci. 89 (2000), pp. 781–789.
   PubMed Web of Science ®Google Scholar
• F. Li, L. Hong, C.I. Mau, R. Chan, T. Hendricks, C. Dvorak, C. Yee, J. Harris, and T. Alfredson, Transport of levovirin prodrugs in the human intestinal Caco-2 cell line, J. Pharm. Sci. 95 (2006), pp. 1318–1325.
   PubMed Web of Science ®Google Scholar
• C.P. Landowski, X. Song, P.L. Lorenzi, J.M. Hilfinger, and G.L. Amidon, Floxuridine amino acid ester prodrugs: Enhancing Caco-2 permeability and resistance to glycosidic bond metabolism, Pharm. Res. 22 (2005), pp. 1510–1518.
   PubMed Web of Science ®Google Scholar
• H. Li, J. Sun, Y. Wang, X. Sui, L. Sun, J. Zhang, and Z. He, Structure-based in silico model profiles the binding constant of poorly soluble drugs with beta-cyclodextrin, Eur. J. Pharm. Sci. 42 (2011), pp. 55–64.
   PubMed Web of Science ®Google Scholar
• H. Li, J. Sun, X. Sui, J. Liu, Z. Yan, X. Liu, Y. Sun, and Z. He, First-principle, structure-based prediction of hepatic metabolic clearance values in human, Eur. J. Med. Chem. 44 (2009), pp. 1600–1606.
   PubMed Web of Science ®Google Scholar